Aspire Life Sciences logo
What we learned from JPM 2026

What we learned from JPM 2026

The 2026 JPM Healthcare Conference reinforced that the healthcare and life sciences sector has entered a more disciplined, execution-led phase. While previous years were defined by headline-grabbing M&A and exuberant valuations, JPM 2026 was about proof points:...